Systems biology of the oxidative stress response

氧化应激反应的系统生物学

基本信息

项目摘要

DESCRIPTION (provided by applicant): This project addresses the fundamental question of how cells adjust their gene expression program in response to oxidative stress (OS) in order to ensure survival. OS, inflicted upon cells either as an intrinsic cost of aerobic metabolism or by extraneous conditions, is intimately linked to a variety of ageing-related diseases, including neurodegenerative disorders, inflammatory conditions, cancer, and the vascular complications of diabetes. OS is known to trigger a transcriptional program primarily geared toward recovery, but triggering cell death if the damage is irreparable. Whereas this program is relatively well characterized at the level of mRNA abundance, almost nothing is known about the coordination with posttranscriptional layers of gene expression control. This application explores the overarching hypothesis that gene expression in response to OS is shaped by an integrated multi-layered program that precisely coordinates transcriptional and posttranscriptional mechanisms to maximize survival. The aim is to describe these mechanisms quantitatively and validating them experimentally both by acquiring global gene expression datasets and by formalizing the connections in mathematical terms. Specifically, a novel model of integrated control is addressed that was inspired by preliminary studies which highlighted the limitations of predicting protein changes from changes in mRNA levels. Mathematical simulations suggested critical roles for control at the levels of mRNA and protein stability during stress that lead to te following propositions: a) Increased synthesis of stress-induced proteins coincides with increased oxidative damage and hence increased proteolytic clearance as a quality control mechanism. b) OS-triggered rapid translational shutdown leads to downregulation of OS-suppressed mRNAs but not proteins in order to liberate ribosome capacity for the efficient translation of OS-induced mRNAs. Within the realm of the proposed project, these predictions will be put to scrutiny by acquiring unique system-wide datasets that will feed into an iterative process of mathematical modeling and experimental validation to arrive at a comprehensive framework of stress-regulated gene expression. The studies also address the general applicability of the OS models for gene expression in response to other forms of environmental stress and to mammalian cells.
描述(由申请人提供):该项目解决了细胞如何调整其基因表达程序以应对氧化应激(OS)以确保生存的基本问题。作为有氧代谢的内在代价或由外部条件对细胞造成的OS与多种衰老相关疾病密切相关,包括神经退行性疾病、炎症性疾病、癌症和糖尿病的血管并发症。已知OS会触发一个主要面向恢复的转录程序,但如果损伤无法修复,则会触发细胞死亡。虽然这个程序是相对较好的特点,在mRNA丰度的水平,几乎没有什么是已知的协调与转录后层的基因表达控制。该应用程序探讨了总体假设,即响应OS的基因表达是由一个集成的多层程序形成的,该程序精确地协调转录和转录后机制,以最大限度地提高生存率。其目的是定量描述这些机制,并通过获取全球基因表达数据集和数学术语形式化的连接来实验验证它们。具体而言,一种新的模型的综合控制的解决,是由初步研究的启发,突出了预测蛋白质的变化,从mRNA水平的变化的局限性。数学模拟表明,在应激过程中,mRNA和蛋白质稳定性水平的控制起着关键作用,这导致了以下命题:a)应激诱导的蛋白质合成增加与氧化损伤增加一致,因此增加了蛋白水解清除率作为质量控制机制。B)OS触发的快速翻译关闭导致OS抑制的mRNA而不是蛋白质的下调,以释放核糖体能力用于OS诱导的mRNA的有效翻译。在拟议项目的范围内,这些预测将通过获取独特的系统范围的数据集进行审查,这些数据集将输入到数学建模和实验验证的迭代过程中,以获得压力调节基因表达的全面框架。这些研究还解决了OS模型对其他形式的环境应激和哺乳动物细胞的基因表达的普遍适用性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DIETER A WOLF其他文献

DIETER A WOLF的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DIETER A WOLF', 18)}}的其他基金

Systems biology of the oxidative stress response
氧化应激反应的系统生物学
  • 批准号:
    9207017
  • 财政年份:
    2014
  • 资助金额:
    $ 37.05万
  • 项目类别:
Systems biology of the oxidative stress response
氧化应激反应的系统生物学
  • 批准号:
    8991929
  • 财政年份:
    2014
  • 资助金额:
    $ 37.05万
  • 项目类别:
Systems biology of the oxidative stress response
氧化应激反应的系统生物学
  • 批准号:
    8632655
  • 财政年份:
    2014
  • 资助金额:
    $ 37.05万
  • 项目类别:
PROTEOMICS
蛋白质组学
  • 批准号:
    8669933
  • 财政年份:
    2013
  • 资助金额:
    $ 37.05万
  • 项目类别:
PROTEOMICS
蛋白质组学
  • 批准号:
    8378398
  • 财政年份:
    2012
  • 资助金额:
    $ 37.05万
  • 项目类别:
PROTEOMICS
蛋白质组学
  • 批准号:
    8181807
  • 财政年份:
    2010
  • 资助金额:
    $ 37.05万
  • 项目类别:
Comprehensive proteomic profiling of the ubiquitin pathway in cancer
癌症中泛素通路的全面蛋白质组学分析
  • 批准号:
    7855709
  • 财政年份:
    2009
  • 资助金额:
    $ 37.05万
  • 项目类别:
Comprehensive proteomic profiling of the ubiquitin pathway in cancer
癌症中泛素通路的全面蛋白质组学分析
  • 批准号:
    7943962
  • 财政年份:
    2009
  • 资助金额:
    $ 37.05万
  • 项目类别:
Optimized High-Throughput Screen for Small Molecule Inhibitors of P27 Degradation
P27 降解小分子抑制剂的优化高通量筛选
  • 批准号:
    7426277
  • 财政年份:
    2007
  • 资助金额:
    $ 37.05万
  • 项目类别:
DE-UBIQUITINATION ENZYMES
去泛素化酶
  • 批准号:
    7420818
  • 财政年份:
    2006
  • 资助金额:
    $ 37.05万
  • 项目类别:

相似海外基金

Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
  • 批准号:
    MR/Y014901/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.05万
  • 项目类别:
    Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
  • 批准号:
    MR/Y014286/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.05万
  • 项目类别:
    Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
  • 批准号:
    MR/Y503502/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.05万
  • 项目类别:
    Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
  • 批准号:
    2317745
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
    Standard Grant
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
  • 批准号:
    10759808
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
  • 批准号:
    10606865
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
  • 批准号:
    10696512
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
  • 批准号:
    10848139
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
  • 批准号:
    MR/Y001095/1
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
    Fellowship
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
  • 批准号:
    488892
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了